Skip to main content
Top
Published in: BMC Nephrology 1/2015

Open Access 01-12-2015 | Research article

Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation

Authors: Jin Ho Hwang, Jiwon Ryu, Jung Nam An, Clara Tammy Kim, Hyosang Kim, Jaeseok Yang, Jongwon Ha, Dong Wan Chae, Curie Ahn, In Mok Jung, Yun Kyu Oh, Chun Soo Lim, Duck-Jong Han, Su-Kil Park, Yon Su Kim, Young Hoon Kim, Jung Pyo Lee

Published in: BMC Nephrology | Issue 1/2015

Login to get access

Abstract

Background

Malnutrition, inflammation, and atherosclerosis (MIA) syndrome is associated with a high mortality rate in patients with end-stage renal disease. However, the clinical relevance of MIA syndrome in kidney transplantation (KT) recipients remains unknown.

Methods

We enrolled 1348 adult KT recipients. Recipients were assessed based on serum albumin, cholesterol, or body mass index for the malnutrition factor and C-reactive protein level for the inflammation factor. Any history of cardiovascular (CV), cerebrovascular, or peripheral vascular disease satisfied the atherosclerosis factor. Each MIA factors were assessed by univariate analysis and we calculated an overall risk score by summing up scores for each independent variable. The enrolled patients were divided into 4 groups depending on the MIA score (0, 2–4, 6, 8–10).

Results

The patients with higher MIA score showed worse outcome of fatal/non-fatal acute coronary syndrome (ACS) (p < 0.001) and composite outcomes of ACS and all-cause mortality (p < 0.001) than with the lower MIA score. In multivariate analysis, ACS showed significantly higher incidence in the MIA score 8-10 group than in the MIA score 0 group (Hazard ratio 6.12 95 % Confidence interval 1.84–20.32 p = 0.003).

Conclusions

The presence of MIA factors before KT is an independent predictor of post-transplant CV outcomes.
Literature
1.
go back to reference Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003;325(4):163–7.CrossRefPubMed Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003;325(4):163–7.CrossRefPubMed
2.
go back to reference Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRefPubMed Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRefPubMed
3.
go back to reference Ishimura E, Shoji T, Emoto M, Motoyama K, Shinohara K, Matsumoto N, et al. Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus. Am J Kidney Dis. 2001;38(4 Suppl 1):S186–90.CrossRefPubMed Ishimura E, Shoji T, Emoto M, Motoyama K, Shinohara K, Matsumoto N, et al. Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus. Am J Kidney Dis. 2001;38(4 Suppl 1):S186–90.CrossRefPubMed
4.
go back to reference Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant. 1997;12(12):2597–602.CrossRefPubMed Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant. 1997;12(12):2597–602.CrossRefPubMed
5.
go back to reference Coresh J, Longenecker JC, Miller ER, Young HJ, Klag MJ. Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S24–30.PubMed Coresh J, Longenecker JC, Miller ER, Young HJ, Klag MJ. Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S24–30.PubMed
6.
go back to reference Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899–911.CrossRefPubMed Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899–911.CrossRefPubMed
7.
go back to reference Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15(7):953–60.CrossRefPubMed Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15(7):953–60.CrossRefPubMed
8.
go back to reference Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15(5):458–82.CrossRefPubMed Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15(5):458–82.CrossRefPubMed
9.
go back to reference Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter. Nephrol Dial Transplant. 2002;17 Suppl 11:28–31.CrossRefPubMed Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter. Nephrol Dial Transplant. 2002;17 Suppl 11:28–31.CrossRefPubMed
10.
go back to reference Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, et al. Inflammatory signals associated with hemodialysis. Kidney Int. 2002;62(4):1408–16.CrossRefPubMed Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, et al. Inflammatory signals associated with hemodialysis. Kidney Int. 2002;62(4):1408–16.CrossRefPubMed
11.
go back to reference Raj DS, Dominic EA, Pai A, Osman F, Morgan M, Pickett G, et al. Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease. Kidney Int. 2005;68(5):2338–44.CrossRefPubMed Raj DS, Dominic EA, Pai A, Osman F, Morgan M, Pickett G, et al. Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease. Kidney Int. 2005;68(5):2338–44.CrossRefPubMed
12.
go back to reference Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001;19(1):53–61.CrossRefPubMed Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001;19(1):53–61.CrossRefPubMed
13.
go back to reference Fishbane S. Cardiovascular risk evaluation before kidney transplantation. J Am Soc Nephrol. 2005;16(4):843–5.CrossRefPubMed Fishbane S. Cardiovascular risk evaluation before kidney transplantation. J Am Soc Nephrol. 2005;16(4):843–5.CrossRefPubMed
14.
go back to reference Patel RK, Mark PB, Johnston N, McGeoch R, Lindsay M, Kingsmore DB, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant. 2008;8(8):1673–83.CrossRefPubMed Patel RK, Mark PB, Johnston N, McGeoch R, Lindsay M, Kingsmore DB, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant. 2008;8(8):1673–83.CrossRefPubMed
15.
go back to reference Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251–63.CrossRefPubMed Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251–63.CrossRefPubMed
16.
go back to reference Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Lindner A, Fornadi K, et al. Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis. 2011;58(1):101–8.CrossRefPubMed Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Lindner A, Fornadi K, et al. Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis. 2011;58(1):101–8.CrossRefPubMed
17.
go back to reference Molnar MZ, Kovesdy CP, Bunnapradist S, Streja E, Mehrotra R, Krishnan M, et al. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant. 2011;11(5):1006–15.CrossRefPubMedPubMedCentral Molnar MZ, Kovesdy CP, Bunnapradist S, Streja E, Mehrotra R, Krishnan M, et al. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant. 2011;11(5):1006–15.CrossRefPubMedPubMedCentral
18.
go back to reference Varagunam M, Finney H, Trevitt R, Sharples E, McCloskey DJ, Sinnott PJ, et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis. 2004;43(3):502–7.CrossRefPubMed Varagunam M, Finney H, Trevitt R, Sharples E, McCloskey DJ, Sinnott PJ, et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis. 2004;43(3):502–7.CrossRefPubMed
19.
go back to reference Ay H, Gungor L, Arsava EM, Rosand J, Vangel M, Benner T, et al. A score to predict early risk of recurrence after ischemic stroke. Neurology. 2010;74(2):128–35.CrossRefPubMedPubMedCentral Ay H, Gungor L, Arsava EM, Rosand J, Vangel M, Benner T, et al. A score to predict early risk of recurrence after ischemic stroke. Neurology. 2010;74(2):128–35.CrossRefPubMedPubMedCentral
20.
go back to reference Fink JC, Onuigbo MA, Blahut SA, Christenson RH, Mann D, Bartlett ST, et al. Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study. Am J Kidney Dis. 2002;39(5):1096–101.CrossRefPubMed Fink JC, Onuigbo MA, Blahut SA, Christenson RH, Mann D, Bartlett ST, et al. Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study. Am J Kidney Dis. 2002;39(5):1096–101.CrossRefPubMed
21.
go back to reference Perez RV, Brown DJ, Katznelson SA, Dubin JA, Muller HG, Chang T, et al. Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation. 2000;69(5):869–74.CrossRefPubMed Perez RV, Brown DJ, Katznelson SA, Dubin JA, Muller HG, Chang T, et al. Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation. 2000;69(5):869–74.CrossRefPubMed
22.
go back to reference van Ree RM, Oterdoom LH, de Vries AP, Gansevoort RT, van der Heide JJ, van Son WJ, et al. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrol Dial Transplant. 2007;22(1):246–53.PubMed van Ree RM, Oterdoom LH, de Vries AP, Gansevoort RT, van der Heide JJ, van Son WJ, et al. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrol Dial Transplant. 2007;22(1):246–53.PubMed
23.
go back to reference Winkelmayer WC, Schaeffner ES, Chandraker A, Kramar R, Rumpold H, Sunder-Plassmann G, et al. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007;20(6):505–11.CrossRefPubMed Winkelmayer WC, Schaeffner ES, Chandraker A, Kramar R, Rumpold H, Sunder-Plassmann G, et al. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007;20(6):505–11.CrossRefPubMed
24.
go back to reference Kruger B, Walberer A, Debler J, Boger CA, Farkas S, Reinhold SW, et al. Is inflammation prior to renal transplantation predictive for cardiovascular and renal outcomes? Atherosclerosis. 2010;210(2):637–42.CrossRefPubMed Kruger B, Walberer A, Debler J, Boger CA, Farkas S, Reinhold SW, et al. Is inflammation prior to renal transplantation predictive for cardiovascular and renal outcomes? Atherosclerosis. 2010;210(2):637–42.CrossRefPubMed
25.
go back to reference Kuhlmann MK, Kribben A, Wittwer M, Hörl WH. OPTA—malnutrition in chronic renal failure. Nephrol Dial Transplant. 2007;22 suppl 3:iii13–iii9. Kuhlmann MK, Kribben A, Wittwer M, Hörl WH. OPTA—malnutrition in chronic renal failure. Nephrol Dial Transplant. 2007;22 suppl 3:iii13–iii9.
26.
go back to reference Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon 3rd RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511.CrossRefPubMed Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon 3rd RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511.CrossRefPubMed
27.
go back to reference Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Haskell WL, Williams PT, et al. Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA. 1990;264(3):359–65.CrossRefPubMed Farquhar JW, Fortmann SP, Flora JA, Taylor CB, Haskell WL, Williams PT, et al. Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA. 1990;264(3):359–65.CrossRefPubMed
28.
go back to reference Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int. 2004;66(1):441–7.CrossRefPubMed Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int. 2004;66(1):441–7.CrossRefPubMed
29.
go back to reference Abedini S, Holme I, Marz W, Weihrauch G, Fellstrom B, Jardine A, et al. Inflammation in renal transplantation. Clin J Am Soc Nephrol. 2009;4(7):1246–54.CrossRefPubMedPubMedCentral Abedini S, Holme I, Marz W, Weihrauch G, Fellstrom B, Jardine A, et al. Inflammation in renal transplantation. Clin J Am Soc Nephrol. 2009;4(7):1246–54.CrossRefPubMedPubMedCentral
30.
go back to reference Gill JS, Ma I, Landsberg D, Johnson N, Levin A. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol. 2005;16(3):808–16.CrossRefPubMed Gill JS, Ma I, Landsberg D, Johnson N, Levin A. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol. 2005;16(3):808–16.CrossRefPubMed
31.
go back to reference Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005;16(2):496–506.CrossRefPubMed Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005;16(2):496–506.CrossRefPubMed
32.
go back to reference Forsythe JL. Graft function and other risk factors as predictors of cardiovascular disease outcome. Transplantation. 2001;72(6 Suppl):S16–9.CrossRefPubMed Forsythe JL. Graft function and other risk factors as predictors of cardiovascular disease outcome. Transplantation. 2001;72(6 Suppl):S16–9.CrossRefPubMed
33.
34.
go back to reference Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol. 2008;51(7):701–7.CrossRefPubMed Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol. 2008;51(7):701–7.CrossRefPubMed
35.
go back to reference Molnar MZ, Keszei A, Czira ME, Rudas A, Ujszaszi A, Haromszeki B, et al. Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis. 2010;56(1):102–11.CrossRefPubMed Molnar MZ, Keszei A, Czira ME, Rudas A, Ujszaszi A, Haromszeki B, et al. Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis. 2010;56(1):102–11.CrossRefPubMed
Metadata
Title
Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation
Authors
Jin Ho Hwang
Jiwon Ryu
Jung Nam An
Clara Tammy Kim
Hyosang Kim
Jaeseok Yang
Jongwon Ha
Dong Wan Chae
Curie Ahn
In Mok Jung
Yun Kyu Oh
Chun Soo Lim
Duck-Jong Han
Su-Kil Park
Yon Su Kim
Young Hoon Kim
Jung Pyo Lee
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2015
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-015-0108-3

Other articles of this Issue 1/2015

BMC Nephrology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.